Background: Rheumatoid arthritis (RA) patients are more likely to experience a
cardiovascularevent (CVE) than the general population. This is a result of atherosclerotic …

Objective Rheumatoid arthritis (RA) is associated with increased cardiovascular event (CVE)
risk. The impact of statins in RA is not established. We assessed whether atorvastatin is …

Objectives Screening for cardiovascular risk factors and treating hyperlipidaemia with statins
are recommended to reduce the increased cardiovascular risk in individuals with …

Data from the TRACE RA trial (n= 3,002; median follow-up 2.5 years) suggest that
atorvastatin 40 mg daily is safe and reduces LDL cholesterol in patients with rheumatoid …

Problem: Rheumatoid arthritis (RA) is a systemic, inflammatory polyarthritis that is
progressive and can be debilitating if left untreated. Cardiovascular disease (CVD) involves …

Background Rheumatoid arthritis (RA) patients have increased cardiovascular disease
(CVD) risk compared to the general population, due to classical and novel risk factors. It is …

Background The beneficial effects of statins in rheumatoid arthritis (RA) have been
suggested previously, but it is unclear whether statins may prevent its development. The aim …

Objective Patients with rheumatoid arthritis (RA) are at significantly higher risk of
cardiovascular (CV) morbidity and mortality compared with the general population …

Background: The anti-inflammatory properties of statins are well documented. The aim of
this study was to determine if statins may offer therapeutic benefits in rheumatoid arthritis …

Introduction To compare statin initiation and treatment non-adherence following a first acute
myocardial infarction (MI) in patients with inflammatory rheumatic disease (IRD) and the …